|
1
|
Chen W, Zheng R, Zhang S, et al: Annual
report on status of cancer in China, 2010. Chin J Cancer Res.
26:48–58. 2014.PubMed/NCBI
|
|
2
|
Berrino F, De Angelis R, Sant M, Rosso S,
Bielska-Lasota M, Coebergh JW and Santaquilani M: EUROCARE Working
group Survival for eight major cancers and all cancers combined for
European adults diagnosed in 1995-99: Results of the EUROCARE-4
study. Lancet Oncol. 8:773–783. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Macfarlane GJ and Boyle P: The
epidemiology of oesophageal cancer in the UK and other European
countries. J R Soc Med. 87:334–337. 1994.PubMed/NCBI
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun JM, Li Q, Gu HY, Chen YJ, Wei JS, Zhu
Q and Chen L: Interleukin 10 rs1800872 T>G polymorphism was
associated with an increased risk of esophageal cancer in a Chinese
population. Asian Pac J Cancer Prev. 14:3443–3447. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoshimoto T, Tsutsui H, Tominaga K,
Hoshino K, Okamura H, Akira S, Paul WE and Nakanishi K: IL-18,
although antiallergic when administered with IL-12, stimulates IL-4
and histamine release by basophils. Proc Natl Acad Sci USA.
96:13962–13966. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zitvogel L, Kepp O, Galluzzi L and Kroemer
G: Inflammasomes in carcinogenesis and anticancer immune responses.
Nat Immunol. 13:343–351. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Born TL, Thomassen E, Bird TA and Sims JE:
Cloning of a novel receptor subunit, AcPL, required for
interleukin-18 signaling. J Biol Chem. 273:29445–29450. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Torigoe K, Ushio S, Okura T, Kobayashi S,
Taniai M, Kunikata T, Murakami T, Sanou O, Kojima H, Fujii M, et
al: Purification and characterization of the human interleukin-18
receptor. J Biol Chem. 272:25737–25742. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Salcedo R, Worschech A, Cardone M, et al:
MyD88-mediated signaling prevents development of adenocarcinomas of
the colon: Role of interleukin 18. J Exp Med. 207:1625–1636. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheung H, Chen NJ, Cao Z, Ono N, Ohashi PS
and Yeh WC: Accessory protein-like is essential for IL-18-mediated
signaling. J Immunol. 174:5351–5357. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sareneva T, Julkunen I and Matikainen S:
IFN-alpha and IL-12 induce IL-18 receptor gene expression in human
NK and T cells. J Immunol. 165:1933–1938. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhernakova A, Festen EM, Franke L, et al:
Genetic analysis of innate immunity in Crohn's disease and
ulcerative colitis identifies two susceptibility loci harboring
CARD9 and IL18RAP. Am J Hum Genet. 82:1202–1210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thompson SR and Humphries SE:
Interleukin-18 genetics and inflammatory disease susceptibility.
Genes Immun. 8:91–99. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sánchez E, Palomino-Morales RJ,
Ortego-Centeno N, Jiménez-Alonso J, González-Gay MA, López-Nevot
MA, Sánchez-Román J, de Ramón E, González-Escribano MF, Pons-Estel
BA, et al: Italian collaborative group: Identification of a new
putative functional IL18 gene variant through an association study
in systemic lupus erythematosus. Hum Mol Genet. 18:3739–3748. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Koskinen LL, Einarsdottir E, Dukes E, Heap
GA, Dubois P, Korponay-Szabo IR, Kaukinen K, Kurppa K, Ziberna F,
Vatta S, et al: Association study of the IL18RAP locus in three
European populations with coeliac disease. Hum Mol Genet.
18:1148–1155. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suppiah V, Moldovan M, Ahlenstiel G, Berg
T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell
E, et al: IL28B is associated with response to chronic hepatitis C
interferon-alpha and ribavirin therapy. Nat Genet. 41:1100–1104.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eurich D, Boas-Knoop S, Ruehl M, Schulz M,
Carrillo ED, Berg T, Neuhaus R, Neuhaus P, Neumann UP and Bahra M:
Relationship between the interleukin-28b gene polymorphism and the
histological severity of hepatitis C virus-induced graft
inflammation and the response to antiviral therapy after liver
transplantation. Liver Transpl. 17:289–298. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen X, Li S, Yang Y, Yang X, Liu Y, Liu
Y, Hu W, Jin L and Wang X: Genome-wide association study validation
identifies novel loci for atherosclerotic cardiovascular disease. J
Thromb Haemost. 10:1508–1514. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Babar M, Ryan AW, Anderson LA, Segurado R,
Turner G, Murray LJ, Murphy SJ, Johnston BT, Comber H, Reynolds JV,
et al: Genes of the interleukin-18 pathway are associated with
susceptibility to Barrett's esophagus and esophageal
adenocarcinoma. Am J Gastroenterol. 107:1331–1341. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Spielman RS, Bastone LA, Burdick JT,
Morley M, Ewens WJ and Cheung VG: Common genetic variants account
for differences in gene expression among ethnic groups. Nat Genet.
39:226–231. 2007. View
Article : Google Scholar : PubMed/NCBI
|
